Global investment firm, KKR, has agreed to acquire Biosynth Carbosynth, a leading life sciences reagents and custom synthesis and manufacturing services company, from Armira, a Munich-based investor, and CEO Urs…
Global investment firm, KKR, has agreed to acquire Biosynth Carbosynth, a leading life sciences reagents and custom synthesis and manufacturing services company, from Armira, a Munich-based investor, and CEO Urs…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


